1-(4-(1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-3-fluorophenyl)-3-(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)urea

ID: ALA4474529

PubChem CID: 118489466

Max Phase: Preclinical

Molecular Formula: C20H21FN8O2

Molecular Weight: 424.44

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cn1nc(C(C)(C)C)cc1NC(=O)Nc1ccc(Oc2ncnc3[nH]ncc23)c(F)c1

Standard InChI:  InChI=1S/C20H21FN8O2/c1-20(2,3)15-8-16(29(4)28-15)26-19(30)25-11-5-6-14(13(21)7-11)31-18-12-9-24-27-17(12)22-10-23-18/h5-10H,1-4H3,(H2,25,26,30)(H,22,23,24,27)

Standard InChI Key:  PFLVNYYIZYFWMD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   12.5344  -17.4871    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8286  -17.8998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5389  -18.3046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2080  -14.5194    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9150  -14.9316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6262  -14.5267    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.9108  -15.7529    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3709  -15.8346    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9156  -16.4439    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5033  -17.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7058  -16.9801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6219  -16.1652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5457  -15.0330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4968  -14.9285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4926  -15.7456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7814  -16.1547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0703  -15.7425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0745  -14.9212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7857  -14.5162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3591  -16.1515    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6436  -18.1991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3547  -18.6113    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.0618  -18.2023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0660  -17.3810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3590  -16.9687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6478  -17.3778    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3254  -17.7960    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8418  -18.4609    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8486  -17.1303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3496  -18.5621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3691  -14.5086    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
  8 12  1  0
  8 13  1  0
  7 12  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 14 19  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 21 26  2  0
 27 28  1  0
 27 29  2  0
 23 28  1  0
 24 29  1  0
 20 25  1  0
 17 20  1  0
  4 14  1  0
 10  2  1  0
  2 30  1  0
 18 31  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4474529

   1-(5-tert-butyl-2-methylpyrazol-3-yl)-3-[3-fluoro-4-(1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)phenyl]urea

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 424.44

Molecular Weight (Monoisotopic): 424.1772

AlogP: 3.96

#Rotatable Bonds: 4

Polar Surface Area: 122.64

Molecular Species: NEUTRAL

HBA: 7

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 10

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.39

CX Basic pKa: 2.51

CX LogP: 3.57

CX LogD: 3.53

Aromatic Rings: 4

Heavy Atoms: 31

QED Weighted: 0.46

Np Likeness Score: -2.40

References

1. Li GB, Ma S, Yang LL, Ji S, Fang Z, Zhang G, Wang LJ, Zhong JM, Xiong Y, Wang JH, Huang SZ, Li LL, Xiang R, Niu D, Chen YC, Yang SY..  (2016)  Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal Model.,  59  (18): [PMID:27535613] [10.1021/acs.jmedchem.6b00604]

Source

Source(1):

• Scientific Literature